ライフサイエンスコーパス: readmission

1 effect (nontargeted procedures also reducing readmissions).

2 related factors were the primary reasons for readmission.

3 orting greater than or equal to one hospital readmission.

4 entified as independent predictors of 30-day readmission.

5 rtery bypass surgery, and 3% died during the readmission.

6 s, reoperation, length of hospital stay, and readmission.

7 on, intra-abdominal abscess, reoperation, or readmission.

8 ing the primary reasons and risk factors for readmission.

9 xamine risk factors associated with repeated readmission.

10 management strategy was not associated with readmission.

11 the combined end point of death and hospital readmission.

12 pital quality may only partially account for readmission.

13 stay were strongly associated with all-cause readmission.

14 Demographic factors did not predict readmission.

15 iteria; 2687 (4.5%) experienced an unplanned readmission.

16 a lower risk of all-cause mortality, but not readmission.

17 The primary outcome was 30-day readmission.

18 6.6%) were the most common cardiac causes of readmission.

19 asive procedures, outpatient encounters, and readmissions.

20 early discharge practices without increasing readmissions.

21 pital stay, postoperative complications, and readmissions.

22 Part B spending, length of stay, and 30-day readmissions.

23 syndrome-related and all-cause 7- and 30-day readmissions.

24 c factors play important roles in predicting readmissions.

25 zation was not independently associated with readmissions.

26 early discharge is associated with increased readmissions.

27 n remain unexplored and are needed to reduce readmissions.

28 year to the same PICU; 3.4% had two or more readmissions.

29 harge mortality related to reducing hospital readmissions.

30 not result in higher-than-expected hospital readmissions.

31 de that had publically reported data on COPD readmissions.

32 nd mitigate potentially preventable post-PCI readmissions.

33 improve perioperative outcomes and decrease readmissions.

34 site end points are used for the analysis of readmissions.

35 tion between hospital TAVR volume and 30-day readmissions.

36 mission 0.88, second readmission 0.90, third readmission 0.44; p > 0.05).

37 and hospital survival (hazard ratios: first readmission 0.88, second readmission 0.90, third readmis

38 azard ratios: first readmission 0.88, second readmission 0.90, third readmission 0.44; p > 0.05).

39 9 surgical readmissions (3.2%), and 4286 RTT readmissions (0.8%); 54.1% of readmissions were for surg

40 ), median length of stay (6 days vs 6 days), readmission (1.9% vs 3.1%), and return to the operating

41 GF (5% vs 20%) and renal dysfunction-related readmissions (10% vs 27.5%) (P < .05 each).

42 (45 [2.0] vs 37 [1.6]; P = .23) and hospital readmissions (107 [4.9] vs 103 [4.4]; P = .42) were unch

43 tay (median: 8 vs 8.5 days; P = .31), 30-day readmission (22.4% vs 21.7%; P > .99), and 90-day mortal

44 ssion was shorter for unplanned than planned readmission (3.2 vs 6.9 d; p < 0.001).

45 ll-cause readmissions (5.9%), 16499 surgical readmissions (3.2%), and 4286 RTT readmissions (0.8%); 5

46 els using a ML approach to predict all-cause readmissions 30 days after discharge from a heart failur

47 lower rates of in-hospital mortality, 30-day readmission, 30-day mortality, and 1-year mortality.

48 cumulative costs were higher for those with readmissions ($39 634 versus $22 058; P<0.001).

49 14.4%; adjusted hazard ratio, 1.14; P=0.01), readmission (45.5% versus 42.1%; hazard ratio, 1.11; P<0

50 vs 19.4 hr; p < 0.01), cardiac surgical ICU readmissions (5.3% vs 1.6%; odds ratio, 0.31; 95% CI, 0.

51 There were 30489 all-cause readmissions (5.9%), 16499 surgical readmissions (3.2%),

52 he regional variation in mortality (65%) and readmission (50%) rates remained unexplained.

53 Ninety-four readmissions (68.6%) were for infection at the same site

54 positivity, permanent colostomy rate, 30-day readmission, 90-day mortality, and overall survival betw

55 ronic conditions was associated with earlier readmission (adjusted hazard ratio, 2.9 for one complex

56 incidence, predictors, and causes of 30-day readmission after hospitalization for CLI.

57 Readmission after pancreatic resection is common and can

58 e common reasons and risk factors for 30-day readmission after pancreatic resection.

59 Readmissions after cardiac procedures are common and con

60 The association of short-term readmissions after percutaneous coronary intervention (P

61 To evaluate nationwide readmissions after peripheral arterial revascularization

62 Data on 30-day readmissions after transcatheter aortic valve replacemen

63 f anastomotic leak, nonroutine discharges or readmission among all four groups.

64 ure of frailty, is associated with unplanned readmission among military veterans following surgery.

65 ith reduced short-term psychiatric inpatient readmissions among psychiatric inpatients with severe af

66 is study aimed to determine the incidence of readmission and factors affecting readmission in CLI pat

67 risk-adjusted measures of quality, including readmission and mortality rates for other conditions, an

68 ld have been substantially altered if 30-day readmission and mortality were considered equally import

69 n current use, and risk factors for surgical readmission and those resulting in return to theater (RT

70 d similar reductions in complications, while readmissions and costs are reduced.

71 gh-risk patients for interventions to reduce readmissions and costs.

72 ories had the highest rates of postdischarge readmissions and ED visits (14.4% and 16.3%, respectivel

73 ries identify populations at risk for 30-day readmissions and ED visits, and do not seem to be mediat

74 modeling approach that categorizes hospital readmissions and emergency department visits as separate

75 option when analyzing heart failure hospital readmissions and emergency department visits.

76 ent frailty, we found no association between readmissions and hospital survival (hazard ratios: first

77 ry, and imaging data with number of hospital readmissions and in-hospital days over the next 12 month

78 Heart failure-related hospital readmissions and mortality are often outcomes in clinica

79 enalties for excess risk-standardized 30-day readmissions and mortality in Medicare patients.

80 uld change if policy equally weighted 30-day readmissions and mortality.

81 To examine the association between COPD readmissions and other quality measures.

82 no correlation between hospital reduction in readmissions and use of observation-only admissions (Pea

83 -year adverse outcomes, including mortality, readmission, and bleeding, for patients with PAD compare

84 healthcare utilization (length of stay, 30-d readmission, and discharge destination) and cost (hospit

85 se, conversion to chronic dialysis, hospital readmission, and long-term mortality.

86 ings, the frequency and amount of physician, readmission, and postacute care payments were evaluated.

87 tivity, permanent ostomy rate, postoperative readmission, and postoperative mortality were also asses

88 hronic condition conferred a greater risk of readmission, and some had considerably higher risk than

89 fections caused by MDROs increase mortality, readmissions, and in some cases, visits to the emergency

90 measurements, length of stay (LOS), hospital readmissions, and mortality.

91 ventilation, all-cause cardiac surgical ICU readmissions, and surgical postponements attributed to l

92 mechanical ventilation, cardiac surgical ICU readmissions, and surgical postponements.

93 ormalities, infection during labor, maternal readmission at 1 year, and in-hospital mortality.

94 Lower readmission at higher-volume hospitals was associated wi

95 effect (future targeted procedures reducing readmission before payments implemented) and a spillover

96 ted time series model to assess the rates of readmission before the Hospital Readmission Reduction Pr

97 hospitals with higher than expected rates of readmission beginning in 2012 for targeted medical condi

98 raditional end points, such as mortality and readmission, but also emphasizes true patient-centered o

99 hyperglycemia was associated with increased readmission, but elevated preoperative HbA1c was not.

100 rivate insurance were least likely to have a readmission compared with Medicaid/no insurance and Medi

101 ficantly higher rates of 1-year mortality or readmission compared with patients without PAD.

102 most to the ability of the mFI to anticipate readmission compared with the other components.

103 t improve prediction of 30-day heart failure readmissions compared with more traditional prediction m

104 -adherent therapy appears to result in fewer readmissions compared with non-guideline-adherent therap

105 nsive Hospital Abstract Reporting System for readmission data analyses.

106 thcare Cost and Utilization Project National Readmission Database encompassing 722 US hospitals was u

107 during 2013 in the United States (Nationwide Readmissions Database) was performed.

108 talization were identified in the Nationwide Readmissions Database.

109 re hospitals participating in the Nationwide Readmissions Database.

110 re identified in the 2013 to 2014 Nationwide Readmissions Databases.

111 eased by 4% per year, and the rate of 30-day readmission decreased by 1% per year.

112 mpensated Heart Failure Reduce Mortality and Readmissions?) demonstrates that the guidance of HF ther

113 ic encephalopathy (HE) is a leading cause of readmission despite standard of care (SOC) associated wi

114 readmission differ from those for all-cause readmission despite the latter being the only measure in

115 nt-related risk factors for surgical and RTT readmission differ from those for all-cause readmission

116 eding was reported in 12 patients (7.1%) and readmission due to UGIB in 4 patients (2.4%) Oesophageal

117 This association was largely driven by readmissions early after discharge and was not significa

118 ay mortality, major morbidity, and unplanned readmissions exist among adult (18-64 yr) and older adul

119 operative complications and 30-day unplanned readmission following discharge.

120 sociation between graft loss, mortality, and readmission for 2 periods: readmission hospitalization a

121 7), in-hospital mortality (p = 0.88), 30-day readmission for chronic obstructive pulmonary disease (p

122 dent increase in postdischarge ED visits and readmission for pain-related diagnoses, but not postdisc

123 However, the chance of readmission for splenectomy after initial nonoperative m

124 stics, the hospitalization rates, and 30-day readmissions for 333,756 hospitalizations among 111,653

125 Readmissions for EOS (within 7 days of birth) were rare

126 ween 24 and 72 hours, clinical outcomes, and readmissions for EOS.

127 omplications and subsequent (within 5 years) readmissions for later postoperative complications, furt

128 ented financial penalties to reduce hospital readmissions for select conditions, including chronic ob

129 hasized the measurement of outcomes (such as readmission, health care-associated infections, and mort

130 included 30-day all-cause mortality, 30-day readmission, hospital length of stay, hospital cost, and

131 s, mortality, and readmission for 2 periods: readmission hospitalization and postreadmission.

132 ng the timeline of risk, that is, during the readmission hospitalization versus periods postreadmissi

133 ted with graft loss and mortality during the readmission hospitalization, but also portends a lasting

134 During the readmission hospitalization, graft loss was substantiall

135 , 1.59; 95% CI, 1.42-1.80), 30-day all-cause readmission (HR, 1.12; 95% CI, 1.01-1.25), and 1-year mo

136 I: 0.84 to 0.96; p = 0.002), but not with HF readmission (HR: 0.93; 95% CI: 0.85 to 1.01) or all-caus

137 HR: 0.93; 95% CI: 0.85 to 1.01) or all-cause readmission (HR: 1.01; 95% CI: 0.95 to 1.08).

138 y resection and total direct cost (including readmission/ileostomy closure hospitalizations) were sig

139 uding delayed graft function, early hospital readmission, immunosuppression intolerance, and mortalit

140 0.54-0.88; P = .002) but for other types of readmission, implant type had no significant association

141 ompare treatment failure leading to hospital readmission in children with complicated appendicitis wh

142 cidence of readmission and factors affecting readmission in CLI patients.

143 (DSM), unplanned reoperation, and unplanned readmission in concurrent versus non-concurrent operatio

144 mary diagnosis changed between admission and readmission in the majority of patients (60.2%) irrespec

145 d with next-day discharge) and the causes of readmission in these 2 patient cohorts.

146 day rates of complications, reoperation, and readmission in urgent cases compared with both elective

147 l: a composite of all-cause mortality and HF readmissions in 180 days and the number of days alive ou

148 ns before discharge may help reduce surgical readmissions in high pain categories.

149 Readmissions in older patients are easier to predict, re

150 made at developing models to predict 30-day readmissions in patients with heart failure, but none ha

151 harge cohorts had similar rates of unplanned readmissions, in-hospital mortality, and acute myocardia

152 The most common reasons for readmission included nonspecific chest pain/angina (24%)

153 The major predictors of 6-month unplanned readmissions included age, female sex, black/Hispanic ra

154 The multivariable analyses showed that readmission increased the log10 cumulative costs by 45%

155 After kidney transplantation, early readmission is independently associated with graft loss

156 Risk of readmission is influenced by CLI presentation, patient d

157 In conclusion, readmission is most strongly associated with graft loss

158 All-cause readmission is the only metric in current use, and risk

159 verall and major complications, </=18.0% for readmission, </=3.1% for positive resection margins, and

160 Medicare and Medicaid Services hospital-wide readmission measure cohort from July 2014 through June 2

161 A transition to a hospital-wide readmission measure would only modestly increase the num

162 ts that changing from the condition-specific readmission measures to a hospital-wide measure would ha

163 icy makers should consider these alternative readmission metrics in strategies for risk reduction and

164 Unplanned readmissions occurred in a sizable minority of PICU pati

165 21 113 (SD 16 881), 17 888 (52.5%) of 34 068 readmissions occurred within 30 days of discharge, and 1

166 d) was not associated with increased risk of readmission (odds ratio 1.12, 95% confidence interval 0.

167 ted with the likelihood of 6-month unplanned readmission (odds ratio for log-transformed length of st

168 adjusted rates 20% vs 16%; P = 0.023), more readmissions (odds ratio 1.57; 95% CI 1.08-2.29; adjuste

169 an 6.5% was associated with decreased 30-day readmissions (odds ratio, 0.85; 95% CI, 0.74-0.96; P = .

170 izations are frequently followed by hospital readmissions, often for recurrent sepsis.

171 was no significant difference in reason for readmission on the basis of discharge timing.

172 a lower risk for the combined endpoint of HF readmission or all-cause mortality (HR: 0.90; 95% CI: 0.

173 Hospital readmission or death occurred in 46% of patients over an

174 The 12-month risk of readmission or death was 63.4% in the home oxygen plus h

175 Time to readmission or death within 12 months adjusted for the n

176 to home oxygen therapy prolonged the time to readmission or death within 12 months.

177 .28; 95% CI, 1.01-1.62) and increased 30-day readmission (OR, 1.30; 95% CI 1.04-1.62) following CEA.

178 ransfusion, therapeutic intervention, 28 day readmission, or death.

179 , without an increase in rates of mortality, readmission, or episodes of suspected infection and susp

180 , percutaneous drain placement, reoperation, readmission, or quality of life scores.

181 less than 1 (ie, superior combined mortality/readmission outcome) with an ERRAGG ratio greater than 1

182 ater than 1 (ie, inferior combined mortality/readmission outcome) with an ERRAGG ratio less than 1, a

183 vational studies that compared mortality and readmission outcomes between patients with ADHF achievin

184 Patients may experience multiple hospital readmissions over time with mortality acting as a depend

185 less than 1, and received minimal mean (SD) readmission penalties (0.08% [0.12%]; P < .001 for compa

186 reater than 1, and received higher mean (SD) readmission penalties (0.41% [0.28%] vs 0.29% [0.37%]; P

187 their components, including index, outlier, readmission, physician services, and postdischarge care.

188 consequences, including re-intubations, ICU readmissions, prolonged ICU and hospital stay, persisten

189 R, 0.96; 95% CI, 0.70-1.32; P = .81), 30-day readmission rate (OR, 0.92; 95% CI, 0.67-1.27; P = .62),

190 Thirty-day readmission rate for all-cause, surgical (defined using

191 The 30-day readmission rate for TAVR was recently reported at 17.9%

192 The 30-day readmission rate was 20.4%.

193 The overall readmission rate was 21.1% (799 patients).

194 ay was 11 (5) days, and the all-cause 30-day readmission rate was 35% (7 of 20 patients).

195 Overall readmission rate was calculated from individual study es

196 The observed readmission rate was consistently higher among patients

197 ssociation between travel time and unplanned readmission rate was evident in all subgroups.

198 discharge outcomes (30-day mortality, 30-day readmission rate, 1-year mortality).

199 -performing quartile (absolute difference in readmission rate, 2.0 percentage points; 95% confidence

200 the effect of travel time to the hospital on readmission rate.

201 (2.0% vs 6.3%, P < 0.01) with similar 30-day readmission rates (10.1% vs 9.8%, P = 0.83).

202 hospitals with the highest risk-standardized readmission rates (RSRRs) subsequently experienced the g

203 revascularization; 30-day risk-standardized readmission rates (RSRRs), calculated using hierarchical

204 am penalizes hospitals that have high 30-day readmission rates across specific conditions.

205 imary outcomes of survival and heart failure readmission rates after ramp testing were assessed.

206 n 1 year apart, and we compared the observed readmission rates among patients who had been admitted t

207 ed hospital-level, risk-standardized, 30-day readmission rates among survivors of sepsis and compared

208 e were significant correlations between COPD readmission rates and all patient experience measures.

209 d the relationship between risk-standardized readmission rates and hospital-level composite measures

210 There were modest correlations between COPD readmission rates and readmission rates for other medica

211 rast, we found low correlations between COPD readmission rates and readmission rates for surgical con

212 tion in 30-day ischemic stroke mortality and readmission rates and the extent to which regional diffe

213 All-cause readmission rates at 30 days and 6 months were 27.1% and

214 There were differences in risk-standardized readmission rates by region (Northeast, 30.4%; South, 29

215 Readmission rates did not differ based on initial manage

216 To evaluate the influence of SDD on 30-day readmission rates following appendectomy for acute appen

217 nsfusion (3.4% vs 2.7%, P < .01), and 1-year readmission rates for myocardial infarction (3.3% vs 2.7

218 injury, 30-day blood transfusion, and 1-year readmission rates for myocardial infarction.

219 relations between COPD readmission rates and readmission rates for other medical conditions, includin

220 relations between COPD readmission rates and readmission rates for surgical conditions, as well as mo

221 Thirty-day readmission rates have gained increasing importance as a

222 that hospital quality contributes in part to readmission rates independent of factors involving patie

223 sociated with an increase in 30-day hospital readmission rates or wound complications when compared w

224 We compared COPD readmission rates to other risk-adjusted measures of qua

225 Readmission rates varied moderately between institutions

226 Thirty-day mortality and readmission rates vary substantially across HRRs and exh

227 and all-cause (OR, 0.50; 95% CI, 0.39-0.64) readmission rates vs children who received other regimen

228 ck of effect of early discharge practices on readmission rates was observed for both minimally invasi

229 The complication and 30-day readmission rates were 27.2% and 14.7%, respectively.

230 We also explored if the change in readmission rates were correlated with changes in index

231 Cardiovascular and HF readmission rates were higher in those with HFrEF and HF

232 Thirty-day readmission rates were significantly lower in high-volum

233 or pneumonia, reductions in hospital 30-day readmission rates were weakly but significantly correlat

234 Secondary outcomes were 30-day all-cause readmission rates, 30-day acute kidney injury, 30-day bl

235 d hospital mortality, home discharge, 30-day readmission rates, and complication rates.

236 30-day readmission rates, causes, and costs of unplanned rehosp

237 herent antibiotics was associated with lower readmission rates.

238 , discharge destination, and 30-day hospital readmission rates.

239 ciated with high postdischarge mortality and readmission rates.

240 inversely associated with 6-month unplanned readmission rates.

241 significant differences in early discharge, readmissions, recurrent emergency department visits, out

242 To understand the impact of the Hospital Readmission Reduction Program on both future targeted an

243 the rates of readmission before the Hospital Readmission Reduction Program was announced (2008-2010),

244 The Hospital Readmission Reduction Program, established under the Aff

245 ement after passage of the Medicare Hospital Readmissions Reduction Program (HRRP) is unknown.

246 s subject to the first cycle of the Hospital Readmissions Reduction Program between July 1, 2008, and

247 The Hospital Readmissions Reduction Program penalizes hospitals that

248 Whether readmission reductions have had the unintended consequen

249 h Revision primary admission diagnoses), and readmissions resulting in RTT.

250 n risk than compatible controls, but a lower readmission risk after the first year than waitlist-only

251 of ECT was associated with a reduced 30-day readmission risk among psychiatric inpatients with sever

252 c regression, to assess for heterogeneity of readmission risk between hospitals.

253 od; however, few studies have determined how readmission risk dynamically changes on a day-to-day bas

254 These findings of ILDKTs having a higher readmission risk than compatible controls, but a lower r

255 ischarge, (2) time required for the adjusted readmission risk to approach plateau periods of minimal

256 heral arterial disease and to assess whether readmission risk varies among hospitals.

257 Readmission risk was determined using multilevel, mixed-

258 effect of patient-related factors on 30-day readmission risk was evaluated by multilevel logistic re

259 sively discharge patients without increasing readmission risk.

260 ant type had no significant association with readmission risk.

261 rtality, all-cause mortality, and HF-related readmission) starting at 3 months.

262 After readmission, the hazard of graft loss remained, but decr

263 In sepsis readmissions, the site and organisms were most commonly

264 and hospitals facing financial penalties for readmission, there has never been a greater need to enfo

265 Thirty-day readmission to hospital after total hip arthroplasty (TH

266 In this large prospective study, readmission to ICU was not an independent risk factor fo

267 o determine the occurrence rate of unplanned readmissions to PICUs within 1 year and examine risk fac

268 ed results demonstrated robust morbidity and readmission trends between non-Hispanic Black and White

269 Probability of readmission was also higher (odds ratio [OR], 2.17; 95%

270 The association of CHD with readmission was assessed to 7 years after delivery.

271 T administration with patient risk of 30-day readmission was estimated using observational, longitudi

272 The most common cause of readmission was procedural complications (28.0%), follow

273 Time to first readmission was shorter for unplanned than planned readm

274 To examine whether ECT's association with readmissions was heterogeneous across population subgrou

275 To assess changes in rates of 30-day readmission, we constructed a Cox proportional hazards m

276 f-stay, infection-related length-of-stay, or readmission were observed between the groups.

277 Median length of stay and cost of readmissions were 4 days (interquartile range, 2-7 days)

278 nce, predictors, causes, and costs of 30-day readmissions were analyzed.

279 The majority of readmissions were because of low-risk chest pain that di

280 Readmissions were because of noncardiac causes in 61.8%

281 Nineteen percent of readmissions were confirmed to be same site and same org

282 Half of readmissions were definitively for new infections, where

283 preventable causes, whereas younger patient readmissions were difficult to predict or prevent (AUC 0

284 , and 4286 RTT readmissions (0.8%); 54.1% of readmissions were for surgical causes.

285 % in high-volume hospitals), whereas cardiac readmissions were more common in high-volume hospitals (

286 Noncardiac readmissions were more common in low-volume hospitals (6

287 or below age 65 revealed that older patient readmissions were more predictable (AUC 0.84) with more

288 5, 95% CI 1.15-1.83) were weak predictors of readmission, while any postoperative complications (OR 2

289 Hospital length of stay and 1-year readmission with inflammatory skin conditions.

290 nction, mortality, reoperation, and hospital readmission, with estimated population attributable frac

291 lso had substantially higher risk for 30-day readmission, with the largest differences at younger age

292 performed to examine factors associated with readmission within 1 year.

293 SDD along with higher incidence of unplanned readmission within 30 days after PCI compared with insur

294 Care discontinuity defined as readmission within 30 days to nonindex hospitals.

295 Primary outcome was readmission within 60 days of surgery.

296 y outcomes included subsequent operation and readmission within 90-day and 1-year follow-up.

297 nt (10,233) of patients had 15,625 unplanned readmissions within 1 year to the same PICU; 3.4% had tw

298 ere (i) death within 30 days, (ii) unplanned readmissions within 30 days, (iii) long length of stay,

299 Unplanned readmissions within 7 and 30 days constituted the coprim

300 s all subsequent hospitalizations and sepsis readmissions within 90 days.